Skip to main content
TipRanks
Go Ultimate75% OFF

TripSitter Clinic Ltd (UY00) AI Stock Analysis

2 Followers
DE:UY00

TripSitter Clinic Ltd

(Frankfurt:UY00)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Reduced cash burnFree cash flow losses have materially narrowed versus the very large outflows in FY2022–FY2024. A smaller absolute cash burn improves runway and reduces near-term refinancing urgency, increasing the odds management can execute a restructuring or revenue restart over months.
Negative Factors
Revenue collapseRevenue near zero eliminates operating scale and renders gross margins and unit economics non-informative. With minimal sales, fixed costs and selling efforts cannot be absorbed, making sustainable profitability dependent on a material and durable revenue reboot or significant restructuring.

TripSitter Clinic Ltd (UY00) vs. iShares MSCI Germany ETF (EWG)

-100%0%100%200%300%400%DE:UY00+200.00%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.27M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-29.7
Beta (1Y)
1.09
Revenue Growth
―
EPS Growth
―
Country
Germany
Employees
0
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

TripSitter Clinic Ltd Business Overview & Revenue Model

Company Description

TripSitter Clinic Ltd. operates a consultative virtual clinic and tele-health platform that connects patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose oral ketamine medication in the United States. Its p...

TripSitter Clinic Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:UY00 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:VHITSE:VHI69NeutralCAD 443.90M40.164.03%―29.32%231.82%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:CHSTSE:CHS42NeutralCAD 10.15M-1.4764.52%―7.63%-106.03%
TSE:UDOCTSE:UDOC41NeutralCAD 4.32M-1.33355.56%―614.03%51.97%
TSE:AIDRTSE:AIDR38UnderperformCAD 44.05M-1.62-444.52%―415.06%-54.80%

* Healthcare Sector Average

Performance Comparison

0%100%200%300%400%DE:UY00TSE:VHITSE:AIDRTSE:CHSTSE:UDOCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:UY00 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:UY00TripSitter Clinic Ltd0.090.06200.00%
TSE:VHIVitalhub Corp.7.00-1.85-20.90%
TSE:AIDRRocket Doctor Ai Inc0.43-0.40-48.21%
TSE:CHSComprehensive Healthcare Systems Inc0.35-0.17-32.69%
TSE:UDOCUnidoc Health Corp.0.05-0.15-75.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.